Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Figure 1 | World Journal of Surgical Oncology

Figure 1

From: Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case report

Figure 1

Abdominal computed tomography (CT) or magnetic resonance imaging (MRI). (a) Abdominal dynamic enhanced MRI obtained before treatment shows multiple liver lesions, the number of nodules >100, the largest diameter was about 1.55 cm; AFP level, 4,773 ng/ml. (b) CT scan obtained 2 months after the start of treatment showed that the lesion was not enhanced in the arterial phase; AFP level, 3.79 ng/ml. (c) CT scan obtained 15 months after the start of treatment showed that the number of low-density lesions was less than before, also no enhancement; AFP level, 3.63 ng/ml. (d) CT scan obtained 21 months after the start of treatment showed that the diffuse liver lesions disappeared, no abnormal enhancement lesions; AFP level, 2.26 ng/ml. (e) MRI scan obtained 46 months after the second treatment showed that there were still no lesions in the liver; AFP, level 3.73 ng/ml.

Back to article page